Former President Donald Trump must have gotten the message that crunchy moms have fallen hard for Robert F. Kennedy Jr., his strong chin, and his strong stance against universal pharmaceuticalization.
On Wednesday, Trump released a video in which he promised, if elected president, to investigate the pharmaceutical industry’s role in the rise of autism, infertility, and illness. Trump has reason to fear being silent about the American people’s poor and rapidly deteriorating health.
NEW — Trump Vows To Investigate Big Pharma For ‘Rise in Autism, Infertility, & Illness’ Among Children
“In recent decades, there has been an unexplained and alarming growth in the prevalence of chronic illnesses and health problems especially in children.
We’ve seen a stunning… pic.twitter.com/TlrhctAt67
— Chief Nerd (@TheChiefNerd) June 7, 2023
In response, Kennedy, who is running for the Democrat presidential nomination, said he loves “this brand of plagiarism” and that he hopes all other presidential candidates will start talking about Americans’ health. If health becomes a theme in the 2024 presidential debates, then Kennedy could have an advantage.
AstraZeneca, Johnson and Johnson, Pfizer, and dozens of other pharmaceutical companies buy up the corporate press’s advertisement space, including as much as 70 percent of prime-time news shows. And they do not seem likely to allow inquiry into the possible connection between rising prescription drug usage and declining life expectancy, increasing disease, and metastasizing chronic health issues among the American people.
But as social media and long-form interviews replace the corporate press, long-silenced questions about health and vitality are emerging. Trump
